Adult-onset Still's disease (AOSD) is a rare autoimmune disorder without clear etiology. It is known that genetic and infectious causes trigger diseases. AOSD cases have been reported after coronavirus disease 2019 (COVID-19) infection and post influenza vaccine. Here, we report this challenging case of adult-onset Still's disease in a patient who recently received the ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844483 | PMC |
| http://dx.doi.org/10.7759/cureus.21279 | DOI Listing |
Publication Analysis
Top Keywords
adult-onset still's
12
still's disease
12
disease
4
disease chadox1
4
chadox1 ncov-19
4
ncov-19 vaccine
4
vaccine adult-onset
4
disease aosd
4
aosd rare
4
rare autoimmune
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!